Clinical Trial Update: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update indicates that Phase 2 and Phase 3 studies of AntiBKV for BK virus infection in kidney transplant recipients have been completed, rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Infection

Drugs mentioned

• AntiBKV

Snippet

Sponsor: Memo Therapeutics AG | Conditions: BK Viremia; BKV DNAemia | Phase 2, Phase 3 | Status: COMPLETED